1279693-56-9

Upstream product

• 910046-59-2 tert-butyl-[(3S)-(4-methoxybenzyloxy)hex-5-enyloxy]diphenylsilane 
• 1207069-48-4 C₃₂H₄₂O₄Si 
• 1207069-45-1 C₃₃H₅₄O₃Si₂ 
• 1207069-46-2 C₂₄H₄₀O₃Si 
• 1207069-44-0 C₅₅H₉₀O₆Si₃ 
• 1207069-43-9 C₅₅H₉₀O₆Si₃ 
• 1207069-51-9 C₄₉H₇₆O₅Si₂ 
• 1207069-55-3 C₄₂H₇₀O₅Si₂ 
• 1207069-41-7 C₄₂H₆₈O₅Si₂ 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 1207069-47-3 C₂₉H₃₆O₄Si 
• 112897-09-3 (3S)-1-{[t-butyl(diphenyl)silyl]oxy}hex-5-en-3-ol 

Relevant academic research and scientific papers

MACROLIDE COMPOUND HAVING ANTICANCER EFFECT

The present invention relates to a macrolide compound expected to have a cell growth-inhibiting activity and a novel anticancer drug utilizing the compound. Specifically, the invention relates to a compound represented by Formula (I) or (II) or a pharmaceutically acceptable salt thereof and relates to a cell growth inhibitor and an anticancer drug each containing the compound or the salt as an active ingredient.

Total synthesis and biological assessment of (-)-Exiguolide and analogues

We describe herein an enantioselective total synthesis of (-)-exiguolide, the natural enantiomer. The methylene bis(tetrahydropyran) substructure was efficiently synthesized by exploiting olefin cross-metathesis for the assembly of readily available acycl